Literature DB >> 22645131

Signaling active CD95 receptor molecules trigger co-translocation of inactive CD95 molecules into lipid rafts.

Isabell Lang1, Andrea Fick, Viktoria Schäfer, Tina Giner, Daniela Siegmund, Harald Wajant.   

Abstract

The capability of soluble CD95L trimers to trigger CD95-associated signaling pathways is drastically increased by oligomerization. The latter can be achieved, for example, by antibodies recognizing a N-terminal epitope tag in recombinant CD95L variants or by genetic engineering-enforced formation of hexamers. Using highly sensitive and accurate binding studies with recombinant CD95L variants equipped with a Gaussia princeps luciferase reporter domain, we found that oligomerization of CD95L has no major effect on CD95 occupancy. This indicates that the higher activity of oligomerized CD95L trimers is not related to an avidity-related increase in apparent affinity and points instead to a crucial role of aggregation of initially formed trimeric CD95L-CD95 complexes in CD95 activation. Furthermore, binding of soluble CD95L trimers was found to be insufficient to increase the association of CD95 with the lipid raft-containing membrane fraction. However, when Gaussia princeps luciferase-CD95L trimers were used as tracers to "mark" inactive CD95 molecules, increased association of these inactive receptors was observed upon activation of the remaining CD95 molecules by help of highly active hexameric Fc-CD95L or membrane CD95L. Moreover, in cells expressing endogenous CD95 and chimeric CD40-CD95 receptors, triggering of CD95 signaling via endogenous CD95 resulted in co-translocation of CD40-CD95 to the lipid raft fraction, whereas vice versa activation of CD95-associated pathways with Fc-CD40L via CD40-CD95 resulted in co-translocation of endogenous CD95. In sum, this shows that signaling-active CD95 molecules not only enhance their own association with the lipid raft-containing membrane fraction but also those of inactive CD95 molecules.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22645131      PMCID: PMC3390677          DOI: 10.1074/jbc.M111.328211

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.

Authors:  R M Siegel; J K Frederiksen; D A Zacharias; F K Chan; M Johnson; D Lynch; R Y Tsien; M J Lenardo
Journal:  Science       Date:  2000-06-30       Impact factor: 47.728

2.  Palmitoylation is required for efficient Fas cell death signaling.

Authors:  Krittalak Chakrabandhu; Zoltán Hérincs; Sébastien Huault; Britta Dost; Ling Peng; Fabien Conchonaud; Didier Marguet; Hai-Tao He; Anne-Odile Hueber
Journal:  EMBO J       Date:  2006-12-07       Impact factor: 11.598

3.  The role of receptor internalization in CD95 signaling.

Authors:  Kyeong-Hee Lee; Christine Feig; Vladimir Tchikov; Robert Schickel; Cora Hallas; Stefan Schütze; Marcus E Peter; Andrew C Chan
Journal:  EMBO J       Date:  2006-02-23       Impact factor: 11.598

4.  The active form of tumor necrosis factor is a trimer.

Authors:  R A Smith; C Baglioni
Journal:  J Biol Chem       Date:  1987-05-25       Impact factor: 5.157

5.  Transition of apoptotic resistant vascular smooth muscle cells to troptotic sensitive state is correlated with downregulation of c-FLIP.

Authors:  T Imanishi; T Hano; I Nishio; W C Liles; S M Schwartz; D K Han
Journal:  J Vasc Res       Date:  2000 Nov-Dec       Impact factor: 1.934

6.  CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway.

Authors:  S Parlato; A M Giammarioli; M Logozzi; F Lozupone; P Matarrese; F Luciani; M Falchi; W Malorni; S Fais
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

7.  Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signaling.

Authors:  Christine Feig; Vladimir Tchikov; Stefan Schütze; Marcus E Peter
Journal:  EMBO J       Date:  2006-12-07       Impact factor: 11.598

8.  Intracellular triggering of Fas, independently of FasL, as a new mechanism of antitumor ether lipid-induced apoptosis.

Authors:  C Gajate; R I Fonteriz; C Cabaner; G Alvarez-Noves; Y Alvarez-Rodriguez; M Modolell; F Mollinedo
Journal:  Int J Cancer       Date:  2000-03-01       Impact factor: 7.396

9.  Death receptor-induced signaling pathways are differentially regulated by gamma interferon upstream of caspase 8 processing.

Authors:  Daniela Siegmund; Andreas Wicovsky; Ingo Schmitz; Klaus Schulze-Osthoff; Sebastian Kreuz; Martin Leverkus; Oliver Dittrich-Breiholz; Michael Kracht; Harald Wajant
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

10.  Trimer stabilization, oligomerization, and antibody-mediated cell surface immobilization improve the activity of soluble trimers of CD27L, CD40L, 41BBL, and glucocorticoid-induced TNF receptor ligand.

Authors:  Agnes Wyzgol; Nicole Müller; Andrea Fick; Sabine Munkel; Goetz Ulrich Grigoleit; Klaus Pfizenmaier; Harald Wajant
Journal:  J Immunol       Date:  2009-07-13       Impact factor: 5.422

View more
  10 in total

1.  Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells.

Authors:  Isabell Lang; Simone Füllsack; Agnes Wyzgol; Andrea Fick; Johannes Trebing; José Antonio Carmona Arana; Viktoria Schäfer; Daniela Weisenberger; Harald Wajant
Journal:  J Biol Chem       Date:  2015-12-31       Impact factor: 5.157

2.  Quantitative analysis of cell surface antigen-antibody interaction using Gaussia princeps luciferase antibody fusion proteins.

Authors:  Juliane Kums; Johannes Nelke; Benedikt Rüth; Viktoria Schäfer; Daniela Siegmund; Harald Wajant
Journal:  MAbs       Date:  2017-01-17       Impact factor: 5.857

3.  MMP7 cleavage of amino-terminal CD95 death receptor switches signaling toward non-apoptotic pathways.

Authors:  Shoji F Kenji; Keerthi Kurma; Brigitte Collet; Christelle Oblet; Laure Debure; Carmelo Di Primo; Laëtitia Minder; Franck Vérité; Yannic Danger; Mickael Jean; Aubin Penna; Nicolas Levoin; Patrick Legembre
Journal:  Cell Death Dis       Date:  2022-10-23       Impact factor: 9.685

Review 4.  Principles of antibody-mediated TNF receptor activation.

Authors:  H Wajant
Journal:  Cell Death Differ       Date:  2015-08-21       Impact factor: 15.828

5.  Lack of Evidence for a Direct Interaction of Progranulin and Tumor Necrosis Factor Receptor-1 and Tumor Necrosis Factor Receptor-2 From Cellular Binding Studies.

Authors:  Isabell Lang; Simone Füllsack; Harald Wajant
Journal:  Front Immunol       Date:  2018-04-23       Impact factor: 7.561

Review 6.  Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor Superfamily.

Authors:  Kirstin Kucka; Harald Wajant
Journal:  Front Cell Dev Biol       Date:  2021-02-11

7.  Vesicle Induced Receptor Sequestration: Mechanisms behind Extracellular Vesicle-Based Protein Signaling.

Authors:  Oskar Staufer; Jochen Estebano Hernandez Bücher; Julius Fichtler; Martin Schröter; Ilia Platzman; Joachim P Spatz
Journal:  Adv Sci (Weinh)       Date:  2022-03-01       Impact factor: 17.521

8.  Constitutive localization of DR4 in lipid rafts is mandatory for TRAIL-induced apoptosis in B-cell hematologic malignancies.

Authors:  M Marconi; B Ascione; L Ciarlo; R Vona; T Garofalo; M Sorice; A M Gianni; S L Locatelli; C Carlo-Stella; W Malorni; P Matarrese
Journal:  Cell Death Dis       Date:  2013-10-17       Impact factor: 8.469

9.  Highly efficient, in-vivo Fas-mediated apoptosis of B-cell lymphoma by hexameric CTLA4-FasL.

Authors:  Alexandra Aronin; Shira Amsili; Tatyana B Prigozhina; Kobi Tzdaka; Roy Shen; Leonid Grinmann; Fanny Szafer; Per Edebrink; Mari-Anne Rauvola; Noam Shani; Michal Dranitzki Elhalel
Journal:  J Hematol Oncol       Date:  2014-09-17       Impact factor: 17.388

10.  Metabolic Fingerprinting of Murine L929 Fibroblasts as a Cell-Based Tumour Suppressor Model System for Methionine Restriction.

Authors:  Werner Schmitz; Corinna Koderer; Mohamed El-Mesery; Sebastian Gubik; Rene Sampers; Anton Straub; Alexander Christian Kübler; Axel Seher
Journal:  Int J Mol Sci       Date:  2021-03-16       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.